Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy

References

• Caricati-Neto A, Errante PR, Menezes-Rodrigues FS. Emerging a new strategy for the antitumor immunotherapy : pharmacological modulation of the Ca 2 +/Camp signaling interaction. Arch Microbiol Immunol. 2017;1(3):89–97. doi:doi:10.26502/ami.93650012
   Google Scholar
• Desantis CE, Fedewa SA, Sauer AG, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015 : convergence of incidence rates between black and white women. A Cancer J Clin. 2016;66(1):31–42. doi:doi:10.3322/caac.21320.
   PubMed Web of Science ®Google Scholar
• Prados J, Melguizo C, Ortiz R, et al. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem. 2012;12(9):1058–1070. doi:doi:10.2174/18715201280352964622339066
   PubMed Web of Science ®Google Scholar
• Huang J, Qian W, Wang L, et al. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer. Int J Nanomedicine. 2016;11:3087–3099. doi:10.2147/IJN.S9272227462153
   PubMed Web of Science ®Google Scholar
• Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535–543. doi:doi:10.1093/humupd/7.6.53511727861
   PubMed Web of Science ®Google Scholar
• Espinosa A, Di Corato R, Kolosnjaj-Tabi J, Flaud P, Pellegrino T, Wilhelm C. Duality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment. ACS Nano. 2016;10(2):2436–2446. doi:10.1021/acsnano.5b0724926766814
   PubMed Web of Science ®Google Scholar
• Foglia S, Ledda M, Fioretti D, et al. In vitro biocompatibility study of sub-5 nm silica-coated magnetic iron oxide fluorescent nanoparticles for potential biomedical application. Sci Rep. 2017;7(April):1–13. doi:10.1038/srep4651328127051
   PubMedGoogle Scholar
• Wu H, Jin H, Wang C, et al. Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery. ACS Appl Mater Interfaces. 2017;9(11):9426–9436. doi:doi:10.1021/acsami.6b1684428247750
   PubMed Web of Science ®Google Scholar
• Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine. 2007;2(2):219–232. doi:doi:10.2217/17435889.2.2.21917716122
   PubMed Web of Science ®Google Scholar
• Liu X, Huang N, Li H, Wang H, Jin Q, Ji J. Multidentate polyethylene glycol modi Fi ed gold nanorods for in vivo near-infrared photothermal cancer therapy. Appl Mater Interfaces. 2014;6:5657–5668. doi:doi:10.1021/am5001823
   PubMed Web of Science ®Google Scholar
• Zhang X, Clime L, Roberge H, et al. pH-triggered doxorubicin delivery based on hollow nanoporous silica nanoparticles with free-standing superparamagnetic Fe 3 O 4 cores. J Phys Chem C. 2011;115:1436–1443. doi:doi:10.1021/jp1075498
   Web of Science ®Google Scholar
• Pandey S, Thakur M, Mewada A, Anjarlekar D, Mishra N, Sharon M. Carbon dots functionalized gold nanorod mediated delivery of doxorubicin: tri-functional nano-worms for drug delivery, photothermal therapy and bioimaging. J Mater Chem B. 2013;1(38):4972–4982. doi:doi:10.1039/c3tb20761g
   PubMed Web of Science ®Google Scholar
• Khafaji M, Vossoughi M, Hormozi-Nezhad MR, Dinarvand R, Börrnert F, Irajizad A. A new bifunctional hybrid nanostructure as an active platform for photothermal therapy and MR imaging. Sci Rep. 2016;6. doi:10.1038/srep27847
   PubMed Web of Science ®Google Scholar
• Elbialy NS, Fathy MM, Reem A-W, et al. Multifunctional magnetic-gold nanoparticles for efficient combined targeted drug delivery and interstitial photothermal therapy. Int J Pharm. 2018;554:256–263.30423414
   PubMedGoogle Scholar
• Guo D, Ji X, Wang H, et al. Silicon nanowire-based multifunctional platform for chemo-photothermal synergistic cancer therapy. J Mater Chem B. 2018;6(23):3876–3883. doi:10.1039/C7TB02907A
   PubMed Web of Science ®Google Scholar
• Sivakumar B, Aswathy RG, Romero-Aburto R, et al. Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents. Biomater Sci. 2017;5(3):432–443. doi:doi:10.1039/c6bm00621c28059418
   PubMedGoogle Scholar
• Oh Y, Je JY, Moorthy MS, Seo H, Cho WH. pH and NIR-light-responsive magnetic iron oxide nanoparticles for mitochondria-mediated apoptotic cell death induced by chemo-photothermal therapy. Int J Pharm. 2017;531(1):1–13. doi:doi:10.1016/j.ijpharm.2017.07.01428689965
   PubMedGoogle Scholar
• Liang P, Chen Y-C, Chiang C, et al. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance chemotherapy. Int J Nanomedicine. 2016;11:2021–2037. doi:doi:10.2147/IJN.S9413927274233
   PubMed Web of Science ®Google Scholar
• Hurley KR, Ring HL, Etheridge M, et al. Predictable heating and positive MRI contrast from a mesoporous silica-coated iron oxide nanoparticle. Mol Pharm. 2016;13(7):2172–2183. doi:doi:10.1021/acs.molpharmaceut.5b0086626991550
   PubMedGoogle Scholar
• Yang Y, Liu J, Sun X, et al. Near-infrared light-activated cancer cell targeting and drug delivery with aptamer-modified nanostructures. Nano Res. 2016;9(1):139–148. doi:doi:10.1007/s12274-015-0898-4
   Web of Science ®Google Scholar
• Kossatz S, Grandke J, Couleaud P, et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17(1):1–17. doi:10.1186/s13058-015-0576-125567532
   PubMedGoogle Scholar
• Benyettou F, Ocadiz Flores JA, Ravaux F, et al. Mesoporous γ-iron oxide nanoparticles for magnetically triggered release of doxorubicin and hyperthermia treatment. Chem - A Eur J. 2016;22(47):17020–17028. doi:10.1002/chem.201602956
   PubMed Web of Science ®Google Scholar
• Hu Y, Hu H, Yan J, et al. Multifunctional porous iron oxide nanoagents for MRI and photothermal/chemo synergistic therapy. Bioconjug Chem. 2018;29(4):1283–1290. doi:10.1021/acs.bioconjchem.8b0005229402074
   PubMedGoogle Scholar
• Lee S, George Thomas R, Ju Moon M, et al. Near-infrared heptamethine cyanine based iron oxide nanoparticles for tumor targeted multimodal imaging and photothermal therapy. Sci Rep. 2017;7(1):1–14. doi:doi:10.1038/s41598-017-01108-528127051
   PubMed Web of Science ®Google Scholar
• Wu M, Zhang D, Zeng Y, Wu L, Liu X, Liu J. Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy. Nanotechnology. 2015;26(11):115102. doi:doi:10.1088/0957-4484/26/11/11510225721867
   PubMed Web of Science ®Google Scholar
• Luo X, Wang Y, Lin H, Qu FDOX. Fe 3 O 4@ mSiO 2-PO-FA nanocomposite for synergistic chemo-and photothermal therapy. RSC Adv. 2016;6(113):112232–112240. doi:10.1039/C6RA23292B
   Web of Science ®Google Scholar
• Yang Y, Wang C, Tian C, Guo H, Shen Y, Fe ZM. 3 O 4@ MnO 2@ PPy nanocomposites overcome hypoxia: magnetic-targeting-assisted controlled chemotherapy and enhanced photodynamic/photothermal therapy. J Mater Chem B. 2018;6(42):6848–6857. doi:10.1039/C8TB02077A
   PubMed Web of Science ®Google Scholar
• Xie W, Gao Q, Wang D, et al. Doxorubicin-loaded Fe 3 O 4@ MoS 2-PEG-2DG nanocubes as a theranostic platform for magnetic resonance imaging-guided chemo-photothermal therapy of breast cancer. Nano Res. 2018;11(5):2470–2487. doi:10.1007/s12274-017-1871-1
   Web of Science ®Google Scholar
• Chen M-L, Gao Z-W, Chen X-M, Pang S-C ZY. Laser-assisted in situ synthesis of graphene-based magnetic-responsive hybrids for multimodal imaging-guided chemo/photothermal synergistic therapy. Talanta. 2018;182:433–442. doi:10.1016/j.talanta.2018.02.03029501175
   PubMedGoogle Scholar
• Chen H, Liu F, Lei Z, Ma L, Wang Z. Fe 2 O 3@ Au core@ shell nanoparticle–graphene nanocomposites as theranostic agents for bioimaging and chemo-photothermal synergistic therapy. RSC Adv. 2015;5(103):84980–84987. doi:10.1039/C5RA17143A
   Web of Science ®Google Scholar
• Seabra AB, Paula AJ, de Lima R, Alves OL, Duran N. Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol. 2014;27(2):159–168. doi:10.1021/tx400385x24422439
   PubMed Web of Science ®Google Scholar
• Li R, Guiney LM, Chang CH, et al. Surface oxidation of graphene oxide determines membrane damage, lipid peroxidation, and cytotoxicity in macrophages in a pulmonary toxicity model. ACS Nano. 2018;12(2):1390–1402. doi:10.1021/acsnano.7b0773729328670
   PubMed Web of Science ®Google Scholar
• Lele BS, Kulkarni MG. Single step room temperature oxidation of poly(ethylene glycol) to poly(oxyethylene)-dicarboxylic acid. J Appl Polym Sci. 1998;70(5):883–890. doi:10.1002/(ISSN)1097-4628
   Web of Science ®Google Scholar
• Morel A-L, Nikitenko SI, Gionnet K, et al. Sonochemical approach to the synthesis of Fe3O4@SiO2 core−shell nanoparticles with tunable properties. ACS Nano. 2008;2(5):847–856. doi:10.1021/nn800091q19206481
   PubMedGoogle Scholar
• Zhu Y, Ikoma T, Hanagata N, Kaskel S. Rattle-type Fe3O4@SiO2 hollow mesoporous spheres as carriers for drug delivery. Small. 2010;6(3):471–478. doi:doi:10.1002/smll.20090140319943250
   PubMed Web of Science ®Google Scholar
• Ding HL, Zhang YX, Wang S, Xu JM, Xu SC, Li GH. Fe3O4@SiO2core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses. Chem Mater. 2012;24(23):4572–4580. doi:10.1021/cm302828d
   Web of Science ®Google Scholar
• Fan H-L, Zhou S-F, Qi G-S, Liu Y-Z. Continuous preparation of Fe3O4 nanoparticles using impinging stream-rotating packed bed reactor and magnetic property thereof. J Alloys Compd. 2016;662:497–504. doi:10.1016/j.jallcom.2015.12.025
   Web of Science ®Google Scholar
• Fidale LC, Nikolajski M, Rudolph T, Dutz S, Schacher FH, Heinze T. Hybrid Fe3O4@ amino cellulose nanoparticles in organic media–heterogeneous ligands for atom transfer radical polymerizations. J Colloid Interface Sci. 2013;390(1):25–33. doi:10.1016/j.jcis.2012.09.01923079041
   PubMedGoogle Scholar
• Lee J, Isobe T, Senna M. Preparation of ultrafine Fe3O4Particles by precipitation in the presence of PVA at high pH. J Colloid Interface Sci. 1996;177(2):490–494. doi:10.1006/jcis.1996.0062
   Web of Science ®Google Scholar
• Zhang C, Wängler B, Morgenstern B, et al. Silica-and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir. 2007;23(3):1427–1434. doi:10.1021/la061879k17241069
   PubMedGoogle Scholar
• Pozzi D, Colapicchioni V, Caracciolo G, et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale. 2014;6(5):2782–2792. doi:doi:10.1039/c3nr05559k24463404
   PubMed Web of Science ®Google Scholar
• Murugan K, Choonara YE, Kumar P, Bijukumar D, Du Toit LC, Pillay V. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015;10:2191.25834433
   PubMed Web of Science ®Google Scholar
• Prijic S, Scancar J, Romih R, et al. Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field. J Membr Biol. 2010;236(1):167–179. doi:doi:10.1007/s00232-010-9271-420602230
   PubMedGoogle Scholar
• Silva AH, Lima E, Mansilla MV, et al. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation. Nanomed Nanotechnol Biol Med. 2016;12(4):909–919. doi:doi:10.1016/j.nano.2015.12.371
   PubMed Web of Science ®Google Scholar
• Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS-Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano. 2011;5(2):1366–1375. doi:doi:10.1021/nn103077k21294526
   PubMed Web of Science ®Google Scholar
• Hu Q, Zhang Y, Wang C, et al. Hemocompatibility evaluation in vitro of methoxy polyethyleneglycol-polycaprolactone copolymer solutions. J Biomed Mater Res - Part A. 2016;104(3):802–812. doi:doi:10.1002/jbm.a.35594
   PubMed Web of Science ®Google Scholar
• Bender EA, Adorne MD, Colomé LM, Abdalla DSP, Guterres SS, Pohlmann AR. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm. 2012;426(1):271–279. doi:10.1016/j.ijpharm.2012.01.05122322210
   PubMedGoogle Scholar
• Zhang Z, Wang J, Nie X, et al. Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods. J Am Chem Soc. 2014;136(20):7317–7326. doi:10.1021/ja412735p24773323
   PubMed Web of Science ®Google Scholar
• Kumar CSSR, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev. 2011;63(9):789–808. doi:10.1016/j.addr.2011.03.00821447363
   PubMed Web of Science ®Google Scholar
• Ma P, Xiao H, Yu C, et al. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett. 2017;17(2):928–937. doi:10.1021/acs.nanolett.6b0426928139118
   PubMed Web of Science ®Google Scholar
• Wang X, Teng Z, Wang H, et al. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system. Int J Clin Exp Pathol. 2014;7(4):1337–1347.24817930
   PubMed Web of Science ®Google Scholar
• Shrikhande SS, Jain DS, Athawale RB, et al. Evaluation of anti-metastatic potential of Cisplatin polymeric nanocarriers on B16F10 melanoma cells. Saudi Pharm J. 2015;23(4):341–351. doi:10.1016/j.jsps.2014.08.00427134534
   PubMed Web of Science ®Google Scholar
• Byeon HJ, Thao LQ, Lee S, et al. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. J Control Release. 2016;225:301–313. doi:10.1016/j.jconrel.2016.01.04626826308
   PubMed Web of Science ®Google Scholar
• Lau JKC, Deubel DV. Hydrolysis of the anticancer drug cisplatin: pitfalls in the interpretation of quantum chemical calculations. J Chem Theory Comput. 2006;2(1):103–106. doi:10.1021/ct050229a26626384
   PubMedGoogle Scholar
• Štarha P, Smola D, Tuček J, Trávníček Z. Efficient synthesis of a maghemite/gold hybrid nanoparticle system as a magnetic carrier for the transport of platinum-based metallotherapeutics. Int J Mol Sci. 2015;16(1):2034–2051. doi:10.3390/ijms1601203425603182
   PubMedGoogle Scholar
• Thapa B, Diaz-Diestra D, Beltran-Huarac J, Weiner BR, Morell G. Enhanced MRI T2Relaxivity in contrast-probed anchor-free PEGylated iron oxide nanoparticles. Nanoscale Res Lett. 2017;12:1–13. doi:10.1186/s11671-017-2084-y28050875
   PubMedGoogle Scholar
• Bian X, Song ZL, Qian Y, et al. Fabrication of graphene-isolated-au-nanocrystal nanostructures for multimodal cell imaging and photothermal-enhanced chemotherapy. Sci Rep. 2014;4:29–32. doi:10.1038/srep06093
   Web of Science ®Google Scholar
• Li L, Nurunnabi M, Nafiujjaman M, Jeong YY, Lee YK, Huh KM. A photosensitizer-conjugated magnetic iron oxide/gold hybrid nanoparticle as an activatable platform for photodynamic cancer therapy. J Mater Chem B. 2014;2(19):2929–2937. doi:10.1039/c4tb00181h
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang S, Zhang Y, et al. Ultra-high relaxivity iron oxide nanoparticles confined in polymer nanospheres for tumor MR imaging. J Mater Chem B. 2015;3(28):5702–5710. doi:10.1039/c5tb00593k
   PubMed Web of Science ®Google Scholar
• Di H, Wu H, Gao Y, Li W, Zou D, Dong C. Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy. Drug Dev Ind Pharm. 2016;42(12):2038–2043. doi:10.1080/03639045.2016.119074327184819
   PubMed Web of Science ®Google Scholar
• Tahover E, Patil YP, Gabizon AA. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes. Anticancer Drugs. 2015;26(3):241–258. doi:10.1097/CAD.000000000000018225415656
   PubMed Web of Science ®Google Scholar
• Ma P, Xiao H, Li C, et al. Inorganic nanocarriers for platinum drug delivery. Mater Today. 2015;18(10):554–564. doi:10.1016/j.mattod.2015.05.017
   Web of Science ®Google Scholar
• Hu Q, Sun W, Wang C, Gu Z. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34. doi:10.1016/j.addr.2015.10.02226546751
   PubMed Web of Science ®Google Scholar
• Unsoy G, Khodadust R, Yalcin S, Mutlu P, Gunduz U. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci. 2014;62:243–250. doi:10.1016/j.ejps.2014.05.02124931189
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Y-C, Dou S, Xiong M-H, Sun T-M, Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano. 2011;5(5):3679–3692. doi:10.1021/nn200007z21462992
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL, Hulikova A. The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc B. 2014.
   PubMed Web of Science ®Google Scholar
• Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small. 2009;5(6):701–708. doi:10.1002/smll.20080154619226599
   PubMed Web of Science ®Google Scholar
• Quinto CA, Mohindra P, Tong S, Bao G. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. Nanoscale. 2015;7(29):12728–12736. doi:10.1039/c5nr02718g26154916
   PubMed Web of Science ®Google Scholar
• Ehlerding EB, Chen F, Biodegradable CW. Renal Clearable Inorganic Nanoparticles. Adv Sci. 2016;3(2):1500223. doi:10.1002/advs.201500223
   Web of Science ®Google Scholar
• Kievit FM, Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res. 2011;44(10):853–862. doi:10.1021/ar200027721528865
   PubMed Web of Science ®Google Scholar
• Kapse-Mistry S, Govender T, Srivastava R, Yergeri M. Nanodrug delivery in reversing multidrug resistance in cancer cells. Front Pharmacol. 2014;5:159.25071577
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang R, Wu C, et al. The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance. J Biomed Mater Res Part A. 2007;80A(4):852–860. doi:10.1002/jbm.a.30901
   Web of Science ®Google Scholar
• Chen Y, Zhang F, Wang Q, et al. The synthesis of LA-Fe 3 O 4@ PDA-PEG-DOX for photothermal therapy–chemotherapy. Dalt Trans. 2018;47(7):2435–2443. doi:10.1039/C7DT04080F
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang X, Li C, et al. Magnetically targeted delivery of DOX loaded Cu 9 S 5@ mSiO 2@ Fe 3 O 4-PEG nanocomposites for combined MR imaging and chemo/photothermal synergistic therapy. Nanoscale. 2016;8(25):12560–12569. doi:10.1039/C5NR06322A26568135
   PubMedGoogle Scholar